Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
The FDA is offering a grant to support research on reducing risks from nitrosamine impurities in human drugs. The goal is to enhance safety while maintaining access to important medications. The recipient of this grant will also explore how to continue this research in collaboration with industry, non-profits, or academia after the funding ends.
The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement.
The proposed work directly supports the U.S. FDA’s stated g…
Funding Source
Awards & funding
Eligibility
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.The FDA will not accept duplicate or highly overlapping applications under review at the same time. This means that the FDA will not accept:•A new (A0) application that is subm…
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers